Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid

Prashant Tembhare, Constance M. Yuan, John C. Morris, John Edward Janik, Armando C. Filie, Maryalice Stetler-Stevenson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma.

Original languageEnglish (US)
Pages (from-to)220-226
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume137
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

T-Cell Antigen Receptor
Needles
Cerebrospinal Fluid
T-Lymphocytes
Residual Neoplasm
Neoplasms
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Anti-Idiotypic Antibodies
Antibodies
Proteins

Keywords

  • Cerebrospinal fluid
  • Fine-needle aspirate
  • Flow cytometry
  • T-cell clonality
  • V repertoire

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid. / Tembhare, Prashant; Yuan, Constance M.; Morris, John C.; Janik, John Edward; Filie, Armando C.; Stetler-Stevenson, Maryalice.

In: American Journal of Clinical Pathology, Vol. 137, No. 2, 01.02.2012, p. 220-226.

Research output: Contribution to journalArticle

Tembhare, Prashant ; Yuan, Constance M. ; Morris, John C. ; Janik, John Edward ; Filie, Armando C. ; Stetler-Stevenson, Maryalice. / Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid. In: American Journal of Clinical Pathology. 2012 ; Vol. 137, No. 2. pp. 220-226.
@article{d88ce58115514cdca4e1b8c47267fa86,
title = "Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid",
abstract = "Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma.",
keywords = "Cerebrospinal fluid, Fine-needle aspirate, Flow cytometry, T-cell clonality, V repertoire",
author = "Prashant Tembhare and Yuan, {Constance M.} and Morris, {John C.} and Janik, {John Edward} and Filie, {Armando C.} and Maryalice Stetler-Stevenson",
year = "2012",
month = "2",
day = "1",
doi = "10.1309/AJCPPT93VZMAREHK",
language = "English (US)",
volume = "137",
pages = "220--226",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid

AU - Tembhare, Prashant

AU - Yuan, Constance M.

AU - Morris, John C.

AU - Janik, John Edward

AU - Filie, Armando C.

AU - Stetler-Stevenson, Maryalice

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma.

AB - Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma.

KW - Cerebrospinal fluid

KW - Fine-needle aspirate

KW - Flow cytometry

KW - T-cell clonality

KW - V repertoire

UR - http://www.scopus.com/inward/record.url?scp=84856370000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856370000&partnerID=8YFLogxK

U2 - 10.1309/AJCPPT93VZMAREHK

DO - 10.1309/AJCPPT93VZMAREHK

M3 - Article

C2 - 22261447

AN - SCOPUS:84856370000

VL - 137

SP - 220

EP - 226

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -